Cite

HARVARD Citation

    Anderson, A. et al. (2016). A safety evaluation of pirfenidone for the treatment of idiopathic pulmonary fibrosis. Expert opinion on drug safety. 15 (7), pp. 975-982. [Online]. 
  
Back to record